Current:Home > reviewsLaunching today: Reporter Kristen Dahlgren's Pink Eraser Project seeks to end breast cancer as we know it -Core Financial Strategies
Launching today: Reporter Kristen Dahlgren's Pink Eraser Project seeks to end breast cancer as we know it
View
Date:2025-04-27 15:16:16
Breast cancer survivors Michele Young, a Cincinnati attorney, and Kristen Dahlgren, an award-winning journalist, are launching a nonprofit they believe could end breast cancer, once and for all.
Introducing the Pink Eraser Project: a culmination of efforts between the two high-profile cancer survivors and the nation's leading minds behind a breast cancer vaccine. The organization, which strives to accelerate the development of the vaccine within 25 years, launched Jan. 30.
The project intends to offer what's missing, namely "focus, practical support, collaboration and funding," to bring breast cancer vaccines to market, Young and Dahlgren stated in a press release.
The pair have teamed up with doctors from Memorial Sloan Kettering, Cleveland Clinic, MD Anderson, Dana-Farber, University of Washington’s Cancer Vaccine Institute and Roswell Park Comprehensive Cancer Center to collaborate on ideas and trials.
Leading the charge is Pink Eraser Project's head scientist Dr. Nora Disis, the director of the University of Washington's Oncologist and Cancer Vaccine Institute. Disis currently has a breast cancer vaccine in early-stage trials.
“After 30 years of working on cancer vaccines, we are finally at a tipping point in our research. We’ve created vaccines that train the immune system to find and destroy breast cancer cells. We’ve had exciting results from our early phase studies, with 80% of patients with advanced breast cancer being alive more than ten years after vaccination,” Disis in a release.
“Unfortunately, it’s taken too long to get here. We can’t take another three decades to bring breast cancer vaccines to market. Too many lives are at stake," she added.
Ultimately, what Disis and the Pink Eraser Project seek is coordination among immunotherapy experts, pharmaceutical and biotech partners, government agencies, advocates and those directly affected by breast cancer to make real change.
“Imagine a day when our moms, friends, and little girls like my seven-year-old daughter won’t know breast cancer as a fatal disease,” Dahlgren said. “This is everybody’s fight, and we hope everyone gets behind us. Together we can get this done.”
After enduring their own breast cancer diagnoses, Dahlgren and Young have seen first-hand where change can be made and how a future without breast cancer can actually exist.
“When diagnosed with stage 4 de novo breast cancer in 2018 I was told to go through my bucket list. At that moment I decided to save my life and all others,” Young, who has now been in complete remission for four years, said.
“With little hope of ever knowing a healthy day again, I researched, traveled to meet with the giants in the field and saw first-hand a revolution taking place that could end breast cancer," she said.
“As a journalist, I’ve seen how even one person can change the world,” Dahlgren said. “We are at a unique moment in time when the right collaboration and funding could mean breast cancer vaccines within a decade."
"I can’t let this opportunity pass without doing everything I can to build a future where no one goes through what I went through," she added.
Learn more at pinkeraserproject.org.
veryGood! (951)
Related
- Louvre will undergo expansion and restoration project, Macron says
- South Korea says it expressed concern to China for sending North Korean escapees back home
- 5 Things podcast: White nationalism is surging. How can it be stopped?
- US says it found health and safety violations at a GM joint venture battery plant in Ohio
- Mets have visions of grandeur, and a dynasty, with Juan Soto as major catalyst
- Nearly 500,000 Little Sleepies baby bibs and blankets recalled due to potential choking hazard
- US defense secretary is in Israel to meet with its leaders and see America’s security assistance
- Songwriter, icon, mogul? Taylor Swift's 'Eras' Tour movie latest economic boon for star
- Residents worried after ceiling cracks appear following reroofing works at Jalan Tenaga HDB blocks
- European Union launches probe as Musk's X claims it removed accounts, content amid Israel war
Ranking
- IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power
- North Korea raises specter of nuclear strike over US aircraft carrier’s arrival in South Korea
- Donald Trump returning to civil trial next week with fixer-turned-foe Michael Cohen set to testify
- Gay and targeted in Uganda: Inside the extreme crackdown on LGBTQ rights
- Romantasy reigns on spicy BookTok: Recommendations from the internet’s favorite genre
- Jury convicts one officer in connection with Elijah McClain's death
- Russian authorities raid the homes of lawyers for imprisoned opposition leader Alexei Navalny
- New Suits TV Series Is in the Works and We Have No Objections, Your Honor
Recommendation
Could your smelly farts help science?
El Niño is going to continue through spring 2024, forecasters predict
In Beirut, Iran’s foreign minister warns war could spread if Israeli bombardment of Gaza continues
Why do people get ink on Friday the 13th? How the day became lucky for the tattoo industry
Will the 'Yellowstone' finale be the last episode? What we know about Season 6, spinoffs
New Hampshire man pleads guilty to making threatening call to U.S. House member
Alabama commission aims to award medical marijuana licenses by the end of 2023
Christopher Reeve's Look-Alike Son Will Turns Heads During Star-Studded Night Out in NYC